|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Corvus Pharmaceuticals (NASDAQ: CRVS) through any online brokerage.
The latest price target for Corvus Pharmaceuticals (NASDAQ: CRVS) was reported by Mizuho on August 3, 2021. The analyst firm set a price target for 3.50 expecting CRVS to fall to within 12 months (a possible -22.05% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Corvus Pharmaceuticals (NASDAQ: CRVS) is $4.49 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Corvus Pharmaceuticals.
Corvus Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 5, 2021.
There is no upcoming split for Corvus Pharmaceuticals.
Corvus Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.